Fast track surgery versus conventional recovery strategies for colorectal surgery by Spanjersberg, W.R. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/95900
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
Fast track surgery versus conventional recovery strategies for
colorectal surgery (Review)
Spanjersberg WR, Reurings J, Keus F, van Laarhoven CJHM
This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library
2011, Issue 2
http://www.thecochranelibrary.com
Fast track surgery versus conventional recovery strategies for colorectal surgery (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
T A B L E O F C O N T E N T S
1HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2PLAIN LANGUAGE SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2SUMMARY OF FINDINGS FOR THE MAIN COMPARISON . . . . . . . . . . . . . . . . . . .
5BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
9RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
Figure 3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Figure 4. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
Figure 5. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Figure 6. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Figure 7. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Figure 8. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Figure 9. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Figure 10. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
Figure 11. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Figure 12. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
Figure 13. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
Figure 14. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
Figure 15. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Figure 16. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
18DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
20AUTHORS’ CONCLUSIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
20REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
23CHARACTERISTICS OF STUDIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
32DATA AND ANALYSES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Analysis 1.1. Comparison 1 Primary analyses ERAS versus conventional, Outcome 1 Mortality. . . . . . . . . 33
Analysis 1.2. Comparison 1 Primary analyses ERAS versus conventional, Outcome 2 All complications. . . . . . 34
Analysis 1.3. Comparison 1 Primary analyses ERAS versus conventional, Outcome 3 Major Complications. . . . 35
Analysis 1.4. Comparison 1 Primary analyses ERAS versus conventional, Outcome 4 Minor complications. . . . . 36
Analysis 1.5. Comparison 1 Primary analyses ERAS versus conventional, Outcome 5 Undefined complications. . . 36
Analysis 1.6. Comparison 1 Primary analyses ERAS versus conventional, Outcome 6 Readmissions. . . . . . . 37
Analysis 1.7. Comparison 1 Primary analyses ERAS versus conventional, Outcome 7 hospital stay. . . . . . . . 38
Analysis 2.1. Comparison 2 Sensitivity analyses ERAS vs conventional, Outcome 1 mortality. . . . . . . . . 39
Analysis 2.2. Comparison 2 Sensitivity analyses ERAS vs conventional, Outcome 2 Total complications. . . . . . 40
Analysis 2.3. Comparison 2 Sensitivity analyses ERAS vs conventional, Outcome 3 Major complications. . . . . 41
Analysis 2.4. Comparison 2 Sensitivity analyses ERAS vs conventional, Outcome 4 Minor complications. . . . . 42
Analysis 2.5. Comparison 2 Sensitivity analyses ERAS vs conventional, Outcome 5 Undefined complications. . . . 42
Analysis 2.6. Comparison 2 Sensitivity analyses ERAS vs conventional, Outcome 6 readmissions. . . . . . . . 43
Analysis 2.7. Comparison 2 Sensitivity analyses ERAS vs conventional, Outcome 7 hospital stay. . . . . . . . 44
44ADDITIONAL TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
46HISTORY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
47CONTRIBUTIONS OF AUTHORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
47DECLARATIONS OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
47DIFFERENCES BETWEEN PROTOCOL AND REVIEW . . . . . . . . . . . . . . . . . . . . .
47INDEX TERMS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
iFast track surgery versus conventional recovery strategies for colorectal surgery (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
[Intervention Review]
Fast track surgery versus conventional recovery strategies for
colorectal surgery
Willem R Spanjersberg1, Jurrian Reurings2 , Frederik Keus1, Cornelis JHM van Laarhoven1
1Department of Surgery, Radboud University NijmegenMedical Center,Nijmegen, Netherlands. 2Department of Surgery, St. Elisabeth
Ziekenhuis, Tilburg, Netherlands
Contact address: Willem R Spanjersberg, Department of Surgery, Radboud University Nijmegen Medical Center, PO Box 9101,
Nijmegen, 6500 HB, Netherlands. w.r.spanjersberg@gmail.com.
Editorial group: Cochrane Colorectal Cancer Group.
Publication status and date: New, published in Issue 2, 2011.
Review content assessed as up-to-date: 3 January 2011.
Citation: Spanjersberg WR, Reurings J, Keus F, van Laarhoven CJHM. Fast track surgery versus conventional recov-
ery strategies for colorectal surgery. Cochrane Database of Systematic Reviews 2011, Issue 2. Art. No.: CD007635. DOI:
10.1002/14651858.CD007635.pub2.
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A B S T R A C T
Background
In recent years the Enhanced Recovery after Surgery (ERAS) postoperative pathway in (ileo-)colorectal surgery, aiming at improving
perioperative care and decreasing postoperative complications, has become more common.
Objectives
We investigated the effectiveness and safety of the ERAS multimodal strategy, compared to conventional care after (ileo-)colorectal
surgery. The primary research question was whether ERAS protocols lead to less morbidity and secondary whether length of stay was
reduced.
Search methods
To answer the research question we entered search strings containing keywords like “fast track”, “colorectal and surgery” and “enhanced
recovery” into major databases. We also hand searched references in identified reviews concerning ERAS.
Selection criteria
We included published randomised clinical trials, in any language, comparing ERAS to conventional treatment in patients with (ileo-
) colorectal disease requiring a resection. RCT’s including at least 7 ERAS items in the ERAS group and no more than 2 in the
conventional arm were included.
Data collection and analysis
Data of included trials were independently extracted by the reviewers. Analyses were performed using “REVMAN 5.0.22”. Data were
pooled and rate differences as well as weighted mean differences with their 95% confidence intervals were calculated using either fixed
or random effects models, depending on heterogeneity (I2).
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Main results
4 RCTs were included and analysed. Methodological quality of included studies was considered low, when scored according to GRADE
methodology. Total numbers of inclusion were limited. The trials included in primary analysis reported 237 patients, (119 ERAS vs
118 conventional). Baseline characteristics were comparable. The primary outcome measure, complications, showed a significant risk
reduction for all complications (RR 0.50; 95% CI 0.35 to 0.72). This difference was not due to reduction in major complications.
Length of hospital stay was significantly reduced in the ERAS group (MD -2.94 days; 95% CI -3.69 to -2.19), and readmission rates
were equal in both groups. Other outcome parameters were unsuitable for meta-analysis, but seemed to favour ERAS.
Authors’ conclusions
The quantity and especially quality of data are low. Analysis shows a reduction in overall complications, but major complications were
not reduced. Length of stay was reduced significantly. We state that ERAS seems safe, but the quality of trials and lack of sufficient
other outcome parameters do not justify implementation of ERAS as the standard of care. Within ERAS protocols included, no
answer regarding the role for minimally invasive surgery (i.e. laparoscopy) was found. Furthermore, protocol compliance within ERAS
programs has not been investigated, while this seems a known problem in the field. Therefore, more specific and large RCT’s are needed.
P L A I N L A N G U A G E S U M M A R Y
Fast track surgery versus conventional recovery strategies for colorectal surgery
Conventionally, recuperation after bowel surgery followed the patients progress. Mobilisation and expansion of diet after surgery was
progressed slowly in a stepwise manner following patients progression. This is because it was believed that faster recovery would be
unwise. In recent years, however, a new concept has been introduced, called Enhanced Recovery after surgery (ERAS) or fast track.
This program, introduced by Kehlet et al, is based on the principle that reducing the body’s stress response after surgery reduces the
time needed to recuperate. This is achieved by interventions around the operation, involving good information, better feeding before
the operation and better pain treatment, so patients can get out of bed earlier and start a normal diet earlier and thereby reducing the
risk of complications. This review investigated whether this intervention is safe and whether it is more effective than the traditional
treatment. In order to answer this question, 4 randomised trials were found, comparing these two interventions. We found that ERAS
can be viewed as safe, i.e. not resulting in more complications or deaths, and at the same time decreases the days spent in hospital
following major bowel surgery. However, the data are of low quality and therefore does not justify implementation of ERAS as the
standard method of care yet. More research on other outcome parameters like economical evaluation and quality of life parameters are
necessary.
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B A C K G R O U N D
Description of the condition
Colorectal carcinoma is one of the malignancies with the highest
incidence in the world and surgery is the main treatment modal-
ity (Weitz 2005). Besides malignancy, other benign conditions
such as diverticulitis and inflammatory bowel disease often require
surgery. Therefore major abdominal surgery with small bowel or
colorectal resections have a high incidence. Surgical approach may
be the conventional open procedure or an laparoscopic resection.
Complication rates after resections, either open or laparoscopic,
are reported as high as 15% and 20% respectively (Tjandra 2006).
Traditionally, the length of hospital stay in recent large trials varies
between5days for laparoscopic surgery and6days for open surgery
in the COST trial (Weeks 2002) and 8.2 (+/- 6.6) days for la-
paroscopic surgery and 9.3 (+/- 7.3) days for open surgery in
the COLOR trial (Hazebroek 2002). Main reasons for increas-
ing length of clinical postoperative treatment are pain, nausea and
persistent ileus (Basse 2000; Basse 2002; Anderson 2003; Kehlet
2003; Basse 2004).
Description of the intervention
In recent years, a trend towards new peri-operative treatment
strategies has been seen; “Fast track surgery” or Enhanced Recov-
ery After Surgery (ERAS). ERAS programs focus on a number
of techniques that facilitate early recovery after major surgery by
preserving pre-operative bodily composition and organ functions.
Techniques include optimal pain control by epidural and local
anaesthesia, minimally invasive techniques, and aggressive post-
operative rehabilitation (Lassen 2009; Wilmore 2001). All these
interventions are chosen on the basis of high-grade evidence of
clinical efficacy. The first to incorporate these strategies in elective
colonic surgery were Kehlet and associates in the mid 90’s, show-
ing a reduction of days to recovery to as early as 2 days postoper-
atively (Kehlet 2007).
How the intervention might work
By reducing stress and pain in colorectal resections, together with
aggressive postoperative mobilisation and early oral feeding, the
body’s stress response is reduced and organ dysfunction is limited
to a minimum, thus facilitating early recovery and reducing post-
operative morbidity and mortality.
Why it is important to do this review
The implementation of ERAS programs in colorectal surgery is
supported by review of controlled trials (Wind 2006) and ran-
domised controlled trials (Khoo 2007). However, the effects of
changing ERAS protocols used and the amount of interventions
used in these protocols set against the recommended set of 17
interventions are not taken into account (Lassen 2009). For this
reason, known RCT’s involving ERAS interventions may hold a
high risk of bias that may not have been sufficiently appreciated
in known meta-analyses. Therefore, by focusing more on quality
of found trials and implementing more stringent inclusion criteria
we tried to increase the level of evidence concerning ERAS pro-
grams in colorectal surgery. With this evidence, the field may be
able tomake amore evidence based decision on implementation of
ERAS protocols. This may well lead to increased or decreased im-
plementation around the world with major implications, both for
patients, organisation of health care and economical cost (Kehlet
2008).
O B J E C T I V E S
To evaluate beneficial and harmful effects of ERAS recovery after
surgery for colorectal carcinomas and benign conditions, by in-
vestigating whether ERAS recovery after colorectal resections dif-
fers in primary (complications, both major, minor and mortal-
ity, and length of hospital stay, including readmissions) and sec-
ondary outcome measures (quality of life, need for re-operation,
better physiological function) in reference to conventional recov-
ery. Other outcome measures, such as cost-effectiveness, time to
return to work, postoperative need for analgesia etcetera were also
investigated.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised clinical trials comparing any type of ERAS recovery
strategy for resections in colorectal disease to conventional recovery
strategies.
Trials will be included irrespectively of blinding, number of pa-
tients randomised, and language of the article. Articles must be
published in peer reviewed indexed journals. Because of expected
flaws in design and the added risk of bias, only randomised trials
were incorporated in this review.
Types of participants
Patients undergoing resection of any portion of the small bowel,
colon or rectum via either laparotomy or laparoscopy.
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Types of interventions
In this review we will compare any type of “ERAS” recovery strat-
egy with conventional recuperation. ERAS recovery strategies in-
clude programs using epidural or local anaesthesia, minimally in-
vasive techniques, optimal pain control and aggressive postopera-
tive rehabilitation to achieve early recovery after colorectal surgery.
In total, 17 items are scored, according to the consensus review of
the ERAS working group (Lassen 2009). An important problem
also to be investigated is the quality of ERAS protocols used in
studies, because detailed review of literature suggests that not all
studies review actual ERAS protocols, but rather conventional care
that has been protocolised. We therefore first scored each proto-
col using the working groups recommendations and recorded the
numbers of items used in each subgroup. We set the debatable
limit at least 7 items used in ERAS groups and no more than 2
items in the conventional groups.
Types of outcome measures
Primary outcomes
Primary outcomes in choosing between interventions should pri-
marily be medical reasons, i.e. safe(r) and better treatment of dis-
ease. The primary outcome parameters in this review therefore will
be:
Mortality (both early and late), with early mortality defined as
death within 30 days was analysed.
Overall complications, and because of different impacts, these
were further divided into both major (including abdominal sepsis,
anastomotic leakage, need for reoperation, persistent ileus, intra-
abdominal abscesses, bleeding, burst abdomen (Platzbauch), late
incisional hernia and adhesions) and minor (pneumonia, wound
infection, deep vein thrombosis, and urinary tract infection) be-
cause safety of this intervention is a major decisional factor in
its implementation. No definition for (specific) complications ex-
ist, so we acknowledge that definitions between studies may vary.
However, for this review we accepted the authors own definitions
at face value.
Additionally, although we do not appreciate it as a medically im-
portant outcome parameter, but since it is an economical parame-
ter thatmay prove important, length of hospital stay; both primary
and total length of stay (including readmissions) are investigated.
This supposition is further supported by GRADE methodology,
as presented by Guyatt (Guyatt 2008), in which the importance of
an outcome to patients is put as the central perspective to establish
importance of outcome parameters. Especially readmissions are
an often feared factor in ERAS programs, because certain com-
plications do not present until ERAS patients have already been
released from clinical care.
Secondary outcomes
Secondary outcome measures are all other outcomes assessed in
comparing the conventional postoperative protocol with ERAS
protocols.
These include operative time, economical evaluation and quality
of life. Depending on availability other outcome data like pain
scores, analgesic use, and other physiological data are analysed.
Search methods for identification of studies
The devised search string was entered in the following databases:
-The Cochrane Database of Systematic Reviews,
-Database of Abstracts of Reviews of Effects (DARE),
-The Cochrane Central Register of Controlled Trials (CEN-
TRAL),
-NHS Economic Evaluation Database, all in The Cochrane Li-
brary (Issue 3, 2008),
-MEDLINE (1985 until present),
-EMBASE (1985 until present) and
-ISI Web of Knowledge (Web of Science) (1985 until present)
-Webcasts of the annualmeetings of theAmericanSociety ofColon
and Rectal Surgeons (ASCRS)
Our aim was to perform a maximal sensitive search in order to
perform a more complete review. Our search strategy has been de-
veloped in accordance to the guidelines outlined in the Cochrane
Handbook for Systematic Reviews of Interventions, chapter 5.2.
The last part of this strategy, concerning the sensitive search for
randomised and controlled trials, corresponds to the Cochrane
Highly Sensitive Search Strategy for Identifying Reports of Ran-
domised Controlled Trials phases 1, 2 & 3. We started the search
from the year 1985 given that ‘ERAS´ approaches were not de-
scribed before 1989 and therefore it would be very unlikely that
any relevant trials will be found prior to this year.
Electronic searches
The specific search strategies that are formed are adapted to the
syntax and capacities of each database. The used implementations
of our search strategy for the different databases are shown in Table
1.
Searching other resources
Additional relevant trials by cross-reference checking will be
looked for in the reference lists of identified randomised trials. Fi-
nally, authors of identified unpublished, or ongoing trials in CEN-
TRAL were contacted to provide relevant preliminary data, but
no data were given. Also, all identified (systematic) reviews con-
cerning ERAS in colorectal surgery were retrieved and references
were hand searched.
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Data collection and analysis
The review was conducted according to the prespecified protocol
(Spanjersberg 2009) and the recommendations by the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins
2008).
Selection of studies
The titles, abstracts and descriptor terms of all downloaded ma-
terial from the electronic searches were read by WRS and irrele-
vant reports discarded. All citations identified were then inspected
independently by WRS and by JCR to establish relevance of the
article according to the pre-specified criteria. If any uncertainty
arose about the relevance of the study, the full article was obtained.
Studies were reviewed for relevance based on study design, types
of participants, types of interventions and outcome measures.
After identifying relevant articles, WRS and JCR independently
applied the inclusion criteria. Differences were resolved by discus-
sion with the third reviewer, CL, and consensus amongst all re-
viewers was reached. All identified trials are listed in the character-
istics of included studies table and excluded trials and the reasons
for exclusion are listed as well (characteristics of excluded studies).
Data extraction and management
Two reviewers (WRS and JR) independently extracted all relevant
data using a specifically designed data extraction form. For each
study patient characteristics, study characteristics, data needed for
the methodological quality assessment of the study and the pri-
mary and secondary outcomes were extracted according to avail-
ability. Data regarding patient characteristics included number
of patients in each group, age, gender, BMI and diagnoses of
included patients. Data regarding study characteristics included
study design, sample size information, inclusion and exclusion cri-
teria of the study, follow-up period, loss to follow-up, surgical ex-
perience and information regarding surgical techniques. For each
study data regarding the perioperative interventions in both the
Enhanced Recovery ERAS group and conventional group were
also extracted. According to the recommendations of the Euro-
pean ERAS Study Group, the ERAS program needs to involve 17
interventions (Lassen 2009). The number of interventions used
in both groups for each study was recorded and presented in the
Characteristics of included studies. The exact interventions used
are graphically depicted in Figure 1. The difference between the
number of intervention used between the conventional and ERAS
groups has to be large enough in order to judge the effect of the in-
tervention named ERAS. We therefore regarded ERAS protocols
implementing 7 or more ERAS items and conventional protocols
implementing no more than 2 items to be adequate for compari-
son.
Figure 1. Number of ERAS items used in included studies (intervention group)
In RCT’s the general descriptive data (like gender, age, body mass
index (BMI), and American Society of Anaesthesiology (ASA)
classification) are supposed to be equally divided due to ran-
domisation. Therefore statistical analysis of patient characteristics
in RCT’s is not appropriate (Assmann 2000). We did, however,
present general descriptive data of included patients in Table 2.
If during data extraction it turns out that essential data or informa-
tion on methods were missing from certain trials/studies, the au-
thors of those trials or studies were contacted and asked to provide
for the missing data. Extracted data was stored and managed us-
ing the review manager software package RevMan, version 5.0.23,
provided by The Cochrane Collaboration.
Assessment of risk of bias in included studies
Assessment of methodological quality of randomised clinical
trials
Based on the available empirical evidence (Schultz 1995; Moher
1998; Kjaergard 2001; Higgins 2008) the methodological quality
of RCTs was assessed using the following items and incorporated
in the Characteristics of included studies section.
Generation of the allocation sequence
Adequate, if the allocation sequence was generated by a computer
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or random number table. Drawing of lots, tossing of a coin, shuf-
fling of cards, or throwing dice was considered as adequate if a
person who was not otherwise involved in the recruitment of par-
ticipants performed the procedure.
Unclear, if the trial was described as randomised, but the method
used for generation of the allocation sequence was not described
or the sequence had an higher risk of bias (like simply randomising
by opening envelopes).
Inadequate, if a system involving dates, names, or admittance
numbers was used for the allocation of patients.
Allocation concealment
Adequate, if the allocation of patients involved a central indepen-
dent unit, on-site locked computer, or sealed envelopes opened by
independent assessors.
Unclear, if the trial was described as randomised, but the method
used to conceal the allocation was not described.
Inadequate, if the allocation sequence was known to the inves-
tigators who assigned participants or if the study was quasi-ran-
domised.
Blinding
Adequate, if the trial was described (at least) as blind to participants
or assessors and themethod of blinding was described.We are well
aware that it is very difficult to properly blind trials comparing
surgical treatments, therefore one level of blinding was considered
adequate.
Unclear, if the trial was described as (double) blind, but themethod
of blinding was not described.
Not performed, if the trial was not blinded.
Follow-up
Adequate, if the numbers and reasons for dropouts and with-
drawals in all intervention groups were described or if it was spec-
ified that there were no dropouts or withdrawals.
Unclear, if the report gave the impression that there had been no
dropouts or withdrawals, but this was not specifically stated.
Inadequate, if the number or reasons for dropouts andwithdrawals
were not described.
These items were scored to assess bias and are depicted as method-
ological summary graph and summary. Further analysis on the
risk of bias and thereby quality of the evidence was performed
using the Grade profiler tool, as provided by the Cochrane collab-
oration. (GRADEprofiler, v3.2.2, © Grade working group, 2004-
2007). Results are shown in Summary of findings for the main
comparison In order to assess the risk of publication bias, funnel
plots were created (Figure 3), and scoring amended accordingly.
Measures of treatment effect
With adequate data available statistical analysis of binary data will
be conducted using relative risks (RR) as the summary statistic.
Trials with zero events in both arms are to be excluded frommeta-
analyses.However, a sensitivity analysis using risk differences (RD)
can be performed with inclusion of these trials, and in case of
inconsistency the results of this sensitivity analysis reported (Keus
2009).
For continuous outcomes weighted mean differences (WMD)
were used as the summary statistic. Authors, however, often pre-
sented their results in medians with ranges due to suspicion of
skewed data, while means with their standard deviations (SD) are
needed for meta-analysis. Then, sensitivity analyses imputing data
for missing means and standard deviations (calculated from avail-
able medians and ranges) was performed (Hozo 2005).
Dealing with missing data
In analysis of data, missing of data is of importance. In case of
missing data we investigated whether this data was missing at
random, in which case the missing data was not regarded as being
of influence on outcome, or data missing not at random, in which
case missing data had to be obtained. Finally, no additional data
had to be obtained.
Assessment of heterogeneity
The main focus of looking at heterogeneity in meta-analysis is to
discriminate true effect modifiers from other sources of hetero-
geneity. Heterogeneity is calculated by the Cochrane Q test and
quantified by measuring I2. If excessive heterogeneity is detected,
data will be re-checked first and then adjusted. Extreme outliers
will be excluded (and tested in sensitivity analyses) when adequate
reasons are available. If excessive heterogeneity still remains, de-
pending on the specific research question, alternative methods will
be considered: subgroup analysis and meta-regression if appropri-
ate.Heterogeneitywas calculated usingHiggins chi-square test and
quantified by measuring I2 (Higgins 2002). A chi-square test with
a P-value of < 0.10 was considered to indicate the presence of het-
erogeneity, while an I2 > 50% was considered to suggest a marked
inconsistency in effect between studies. In case of no discrepancy
(and no heterogeneity) the fixed-effect models is presented. The
fixed-effect model was only used if no or low heterogeneity was
present (I2 <25%). In all other cases the random-effects model was
used. Both the random-effects model (Dersimonian 1986) and
the fixed-effect model (Demets 1987) for pooling effect estimates
were explored.
In case of discrepancy between the two models (e.g., one giving
a significant intervention effect and the other no significant in-
tervention effect) both results are reported. Discrepancy will only
occur when substantial heterogeneity is present.
Most weight will be put on the results of the fixed-effect model if
the meta-analysis includes one or more large trials, provided that
they have adequate methodology. (By large trials we mean trials
that outnumber the rest of the included trials in terms of numbers
of outcomes and participants (e.g., more than half of all included
events and participants)).
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Otherwise, most weight will be put on the results of the random-
effectsmodel as it incorporates heterogeneity. The reason for this is
that the random-effects model increases the weight of small trials.
Small trials however are more often than large trials conducted
with unclear or inadequate methods (Kjaergard 2001).
Finally, in situations of excessive heterogeneity we refrained from
reporting a pooled estimate when inappropriate.
Assessment of reporting biases
We used funnel plots to provide a visual assessment of whether
treatment estimates are associated with study size. The presence
of publication bias and other biases (Begg 1994; Egger 1997;
Macaskill 2001) varies with the magnitude of the treatment effect,
the distribution of study size, and whether a one- or two-tailed
test is used (Macaskill 2001).
Subgroup analysis and investigation of heterogeneity
If excessive heterogeneity was present, data were re-checked first.
If heterogeneity persisted, subgroup or sensitivity analyses were
used to explore its causes. When adequate reasons were present
extreme outliers were excluded in sensitivity analyses. In situations
of excessive heterogeneity that could not be explained, we refrained
from reporting a pooled estimate.
Subgroup analyses was performed to compare the effects of the
interventions according to themethodological quality of the trials,
i.e. low level RCT’s were included in analysis. Furthermore, causes
of contingent heterogeneity (defined as the presence of statistical
heterogeneity by chi-squared test with significance set at P-value <
0.10 and measured by the quantities of heterogeneity by I2 (Hig-
gins 2005, section 8.7.2)) were explored by comparing stratifica-
tion between true ERAS protocols and other recovery strategies.
An ERAS protocol was considered true when a minimal set of 7
ERAS interventions were used.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of ongoing studies.
Results of the search
The systematic searchwas conducted in The Cochrane Library, Is-
sue 1, 2009 (22 hits, 1 selected), TheNational Library ofMedicine
(MEDLINE) via PubMed (125 hits, 17 selected), Exerpta Med-
ica via EMBASE (82 hits, 12 selected), ISI Web of Knowledge
(135 hits, 14 selected), and web casts of the annual meetings of
the American Society of Colon and Rectal Surgeons (ASCRS) (all
published web cast until 2009, 0 selected). For detailed informa-
tion about the search strategies and the numbers of hits we refer
to additional Table 1. Altogether, the search resulted in 364 hits.
After correction for duplicates, 241 publications remained.The
first selection was performed based on the titles of publications
and all clearly irrelevant publications were excluded. A total of 72
hits were considered possibly relevant based on their titles. The
abstracts of these 72 publications were reviewed independently by
two reviewers (WRS and JR). Differences between WRS and JR
were discussed with CVL. A total of 55 publications could be re-
jected based on their abstracts. Eventually, 18 publications were se-
lected for further evaluation and these are listed in this review with
reasons for in- and exclusion. Also, 4 systematic reviews were iden-
tified (Wind 2006; Walter 2009; Gouvas 2009; Varadhan 2010)
and included studies in these reviews, along with the reference lists
were hand searched. No additional hits were identified.
Included studies
After completion of the search and complete review of the 18 se-
lected remaining manuscripts, 6 RCTs were included in this re-
view for all secondary analysis and background characteristics(see
Characteristics of included studies). However, since 2 trials used
insufficient number of ERAS items used in the protocol, only 4
RCT’s were included in primary analysis.(Anderson 2003; Gatt
2005; Khoo 2007; Serclova 2009). The 6 trials included 452 pa-
tients, of whom 226 patients received ERAS treatment, and 226
patients received traditional care. Patient characteristics are de-
picted in Table 2. Inclusion criteria for all studies were similar;
most included both benign and malignant disease. Majority of
diagnosis consisted of malignant colon disease and inflammatory
bowel diseases (i.e. Crohn’s disease or ulcerative colitis), and in-
cluded patients needed to be independently living at home. All
studies only included elective surgery, and exclusion criteria were
similar for most studies. Delaney et al, however, also included
patients needing re-operations, including pelvic surgery. Baseline
characteristics were similar for all studies. No significant differ-
ences in age and sex existed. The majority of included patients
were classified as ASA 1 or 2. Not all studies listed the ASA clas-
sification.
Number of ERAS points used
As mentioned, a complete peri-operative pathway according to
ERAS principles includes 17 separate interventions (Lassen 2009).
The actual number of interventions used differed greatly between
included trials. Trials that were considered high quality used 11
or 12 of the 17 ERAS prespecified interventions versus 0 or 1 in
the conventional group (pertaining epidural analgesia) (Anderson
2003; Gatt 2005; Serclova 2009). On the other hand, 2 trials in-
corporated only 4 or 6 ERAS items, while Muller also incorpo-
rated 4 ERAS items in the conventional group (Muller 2009).
Trials included for primary analysis
Since this clearly represents a bias on outcome analysis, primary
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analysis was performed on 4 RCTs incorporating no less than 7
items in the ERAS protocol and no more than 2 in the conven-
tional group. To investigate effects when these trials were taken
into account, a sensitivity analysis was performed, including afore-
mentioned trials. Primary analysis resulted in a total inclusion for
primary analysis of 4 RCT’s, including 237 patients; 119 received
ERAS treatment and 118 patients received conventional treat-
ment.
Indication
Indications for resection are mentioned in the Included studies
section. Indications were similar throughout the included studies
and represent the normal clinical indications encountered during
daily practice. Some also included pelvic surgery and/or rectal
resections with TME. Whether these resections are fit for ERAS
is unknown, so we found no reason to exclude these patients from
analysis.
Technique
All randomised patients received segmental resection of colon, rec-
tum and/or ileum by open surgical technique. Although inclu-
sion criteria for this review also included laparoscopic techniques,
no studies comparing conventional recuperation to laparoscopic
technique with ERAS were identified.
Trial designs
All included trials can be classified as randomised controlled trials.
Most were monocentric trials, except Muller 2009 (4 centres).
Excluded studies
From the selected 18, a total of 12 publications were excluded (see
’Excluded studies’ table). Reasons for exclusion are mentioned in
this table, mostly reasons for exclusion consisted of pseudo ran-
domised studies and comparison of groups both receiving ERAS
protocol treatment.
Risk of bias in included studies
The risk of bias for every included trial was assessed using the
RevMan bias assessment tool and using the GRADE profile soft-
ware. The under mentioned items were scored to assess bias and
are depicted as methodological summary graph (Figure 2) and
summary (Figure 3). Results are also depicted in the character-
istics of included studies and Summary of findings for the main
comparison.
Figure 2. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
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Figure 3. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
Allocation
Allocation sequences for included trials showed different risk for
bias. Several trials used sealed envelopes for generating allocation,
without reporting the exact sequence. It is known that the use of
envelopes can result in bias, when care providers have an interest
in allocating certain patients to the preferred treatment method.
Blinding
None of the included trials used blinding, nor for the patients nor
for the treating surgeon. However, the investigated intervention
(ERAS) has an intrinsic problem with blinding; an important in-
tervention in ERAS is the pre-operative information provided to
patients, which provides knowledge pertaining the operation and
the expected peri- and postoperative course. Therefore, blinding
patients is not possible. Blinding the surgeon is also restricted,
because of the differences in surgical approach and postoperative
care. However, blinding of outcome using an impartial outcome
assessor is possible, but no adequate blinding was performed in
included trials.
This may not be a problem, except when different surgeons are
involved in caring for these patients and these surgeons have dif-
ferent experiences and preferences towards ERAS. This was the
case in one trial (Delaney 2003) and this effect was also investi-
gated. Analysis showed that ERAS surgeons caring for ERAS pa-
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tients actually showed better results (especially in length of stay)
than traditional surgeons caring for ERAS patients. In fact, ERAS
surgeons caring for conventional patients, also showed a shorter
length of stay than conventional surgeons caring for conventional
patients. Also, confounding could have been present by imple-
menting both an ERAS care pathway and conventional care in the
same hospital ward, presenting the risk of “cross contamination”
by one protocol to another.
Incomplete outcome data
Most data that was described by authors as being recorded during
trials are also reported. One outcome parameter that was insuf-
ficiently recorded was the effect of readmissions on hospital stay.
Only 1 study (Khoo 2007) reported the length of stay associated
with readmissions, however, only as absolute stay and this was not
included in analysis.
Selective reporting
Data recorded was mostly reported, and therefore the risk of selec-
tive reporting seems to be small. However, a lot of data is reported
as median with interquartile range, suggesting large outliers in the
raw data. In the relative small populations studied, this could rep-
resent a bias, when these outliers occurred mostly in one of the
groups.
Other potential sources of bias
Another potential source of bias in measuring the treatment effect
of ERAS is the fact that in the conventional protocol, some of the
ERAS interventions are also used. And since the exact contribution
of the separate interventions in ERAS protocols are not known, the
measured effect can be biased by these interventions used in the
conventional protocol. In Figure 1, the number of interventions
used in the ERAS protocols used in the included studies are shown.
Publication bias was investigated using funnel plots (Figure 3).
The risk of this bias can be considered as low, and therefore, no
downgrading was performed on this item.
Effects of interventions
See: Summary of findings for the main comparison Primary
analyses ERAS versus conventional for colorectal surgery
Primary analysis
As mentioned, primary analysis of pooled data was performed on
4 RCT’s that were deemed of high(er) quality, because of the ratio
of ERAS items used in their protocols (Anderson 2003;Gatt 2005;
Khoo 2007; Serclova 2009).
Primary outcome measures
Mortality
Mortality after elective colorectal surgery is exceedingly rare. Mor-
tality in included studies was 1 (0.4%) in ERAS patients versus
3 (1.3%) in conventional patients (Analysis 1.1,Figure 4), and
showed no statistical difference between groups ((RR 0.53; 95%
CI 0.12 to 2.38))
Figure 4. Forest plot of comparison: 1 Primary analyses ERAS versus conventional, outcome: 1.1 Mortality.
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Complications
In the ERAS group 34 (28.5%) patients sustained complications,
while 67 (56.8%) patients in the conventional group encoun-
tered complications (Analysis 1.2; Figure 5). The ERAS patients
encountered significantly less complications (RR 0.52; 95% CI
0.38 to 0.71), p<0.0001). Since not all complications represent
the same negative risk for an intervention, complications were di-
vided into major and minor complications, and where the exact
complications were not explicated, they were deemed undefined.
Figure 5. Forest plot of comparison: 1 Primary analyses ERAS versus conventional, outcome: 1.2 All
complications.
Major complications occurred in 6 (8.8%) of ERAS patients and
in 14 (21.2%) of conventionally treated patients (RR 0.45; 95%
CI 0.09 to 2.32, p=0.34) (Analysis 1.3.Figure 6). These included
mortality. In total, 17 (25%) of ERAS patients endured minor
complications versus 26 (39.4%) of conventionally treated pa-
tients. (RR 0.63; 95% CI 0.38 to 1.05) (Analysis 1.4,Figure 7),
and 11 ERAS patients versus 7 conventional patients endured an
undefined complication (described as no serious complications)
(Analysis 1.5; Figure 8).
Figure 6. Forest plot of comparison: 1 Primary analyses ERAS versus conventional, outcome: 1.3 Major
Complications.
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Figure 7. Forest plot of comparison: 1 Primary analyses ERAS versus conventional, outcome: 1.4 Minor
complications.
Figure 8. Forest plot of comparison: 1 Primary analyses ERAS versus conventional, outcome: 1.5 Undefined
complications.
Readmissions
In total, 4 patients (3.3%) from the ERAS study group and 5
patients (4.2%) in the conventional group had to be readmitted.
(RR 0.87; 95% CI 0.08 to 9.39; Analysis 1.6,Figure 9) The effect
on total hospital stay could not be clearly identified. However, one
ERAS patient did have to be readmitted for 7 days (Khoo 2007),
which could effect the analysis.
Figure 9. Forest plot of comparison: 1 Primary analyses ERAS versus conventional, outcome: 1.6
Readmissions.
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Length of hospital stay
Primary outcome measures were defined as length of hospital stay
and complications, including readmissions. The total length of
hospital stay was defined in included studies as the primary length
of stay. Insufficient data on added length of stay due to readmis-
sionswas available. The primary length of stay (Analysis 1.7; Figure
10) was shorter for the ERAS treated patients (MD -2.94 days;
95% CI -3.69 to -2.19). Since not all reasons for readmissions are
reported, the effect on hospital stay is unknown.
Figure 10. Forest plot of comparison: 1 Primary analyses ERAS versus conventional, outcome: 1.7 hospital
stay [days].
further reported outcome measures
All studies reported a number of additional outcome measures.
These were very heterogenic, and therefore not suitable for meta-
analysis.
gastro-intestinal function
Four studies reported on gastro-intestinal function postopera-
tively. One trial (Gatt 2005) showed a significant shorter time to
oral feeding for ERAS patients (48 vs 90h, p0.042), as did Khoo
et al, with ERAS patients tolerating a solid diet on postoperative
day 1 (range 0-6 days) against 4 days for the conventional group
(range 2-9 days). The bowel function, defined as passing stool
or functioning stoma, was also shorter for ERAS patients in this
study; 3 days [1-5] for ERAS patients versus 5 [0-23] for con-
ventionally treated patients (p<0.001). Anderson also reported an
earlier return of gut function, defined as tolerating 3 light meals a
day for ERAS patients (48[33-55]h vs 76[70-110)h, respectively),
as did Serclova, with earlier bowel movement (1.3±0.8 vs 3.1±1.0
days) and passing stool sooner (2.1±1.1 vs 3.9±1.1 days) for the
ERAS treated patients. they also reported significantly more nau-
sea in the conventional group on postoperative days 2-4, without
an effect of the use of nasogastric tubes.
intravenous fluid administration
Analogue to earlier solid diet and normalisation of gastro-intesti-
nal function, several trials also reported on the need for supple-
mental intravenous fluid. In the Anderson trial, iv fluids were dis-
continued at a median of 36 hours [24-37] in the ERAS group
versus 57h [42-105] in controls (p=0.001). Gatt found a similar
effect with discontinuing iv fluids at median 33.2 hours for the
ERAS group vs 68h for controls (p=0.007). Restriction of peri-
operative fluid administration is one of the ERAS working groups
recommendations. However, only 2 of the included trials used this
in their ERAS protocols. Muller did find in a secondary analysis
that along with effective epidural analgesia, perioperative fluid re-
striction was an independent predictor for complications. intra-
operative fluid administration was lower for ERAS patients here
(1925mL vs 2950mL median, p<0.001)
pain scores and analgesia
The use of analgesics varied greatly between study protocols. In
some studies, epidural analgesia was used for all patients (Muller
2009; Khoo 2007; Gatt 2005; Serclova 2009), while one trial did
not incorporate epidurals at all (Delaney 2003). The only trial that
only used epidurals for ERAS patients (Anderson 2003) showed a
significant increase in pain postoperatively in control patients on
coughing, movement and at rest for the conventional group, while
no increase was found for the ERAS group. Only by day 7, pain
scores were similar between both groups, but pain on coughing re-
mained significantly increased in controls. Delaney usedmorphine
Patient Controlled Analgesia for all patients, that was changed
for oral oxycodone on day 2 in ERAS patients and when control
patients tolerated oral fluids. They found no differences in the
amount of opiates used or in pain scores. Four studies that used
epidural analgesics (EDA) in all patients, and 3 did not report
postoperative pain scoring (Khoo 2007; Gatt 2005;Muller 2009).
Muller did report similar effective EDA analgesia between both
groups (79 vs 80%), while Serclova at all reported the use of EDA
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in 100% of ERAS patients and 62% in controls. 14% of EDA
in ERAS patients failed versus 28% in controls. VAS scores, both
highest recorded per day and median, were significantly lower for
ERAS patients between postop days 0-5 (p,0.001).
mobilisation
Trials that reported on postoperative mobilisation showed an over-
all better mobilisation for ERAS patients. Both mobilisation on
postop day 0 (Serclova 2009) and day 1 (Gatt 2005) was better
for ERAS patients. this did not result in better physiological pa-
rameters however, since FEV1 and FVC was significantly reduced
in both ERAS and controls postoperatively and no difference be-
tween the groups was recorded (Gatt 2005). Other outcome mea-
sures reflecting improved preservation of physiology also showed
no differences between both groups; hand grip strength showed
no difference (Gatt 2005) and quality of life scores also showed
no differences (Delaney 2003).
duration of surgery
Duration of surgery was only reported in one trial (Muller 2009),
and showed no difference in median duration of surgery (140 vs
120 minutes). However, the incision used was also the same for
both study arms.
other outcome measures
No studies investigated cost effectiveness of ERAS protocols, nor
was anymention on the influence of ERAS on quality of life found.
Also, no study investigated ERAS failure, i.e. individual patients
within anERAS programdisplaying failure to thrive.Moreover, no
study reported on the compliance of individual ERAS itemswithin
their study protocols, while lack of compliance will inevitably lead
to bias in data provided.
sensitivity analysis
As mentioned, 2 of the included trials used a very limited number
of ERAS items. When we did include these trials in analysis, these
6 RCT’s included 452 patients, 226 patients per study group. The
mortality analysis did not differ, because neither of the 2 trials
reported mortality.
Complications
The total number of complications for the entire population was
54 for the ERAS group versus 105 for conventional patients (RR
0.51; 95% CI 0.39 to 0.67)(Analysis 2.2; Figure 11). This was
further subdivided intomajor complications; 14 for ERASpatients
versus 28 in conventional patients (RR 0.50; 95% CI 0.28 to
0.92)(Analysis 2.3,Figure 12) and minor complications; 29 for
ERAS patients versus 50 for conventional groups (RR 0.57; 95%
CI 0.38 to 0.85) (Analysis 2.4; Figure 13,Figure 14).
Figure 11. Forest plot of comparison: 2 Sensitivity analyses ERAS vs conventional, outcome: 2.2 Total
complications.
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Figure 12. Forest plot of comparison: 2 Sensitivity analyses ERAS vs conventional, outcome: 2.3 Major
complications.
Figure 13. Forest plot of comparison: 2 Sensitivity analyses ERAS vs conventional, outcome: 2.5 Minor
complications.
Figure 14. Forest plot of comparison: 2 Sensitivity analyses ERAS vs conventional, outcome: 2.5 Undefined
complications.
Readmissions
The number of readmissions showed no significant differences
between both groups (RR 0.79; 95% CI 0.36 to 1.76) (Analysis
2.6; Figure 15). In total, 10 ERAS patients had to be readmit-
ted against 13 conventionally treated patients.There were now 10
readmissions in the ERAS population and 13 in the conventional
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group
Figure 15. Forest plot of comparison: 2 Sensitivity analyses ERAS vs conventional, outcome: 2.3
readmissions.
Hospital stay
The length of hospital stay for all trials was shorter in sensitivity
analysis; MD -2.51 days; 95% CI -3.54 to -1.47, which was sig-
nificant (p<0.00001) (Analysis 2.7; Figure 16).
Figure 16. Forest plot of comparison: 2 Sensitivity analyses ERAS vs conventional, outcome: 2.4 hospital
stay [days].
D I S C U S S I O N
Summary of main results
This review searched for any RCT comparing conventional re-
covery strategies to ERAS recovery strategies after ileo-colorectal
surgery. In all 17 RCT’s were identified, and after applying selec-
tion criteria, 6 RCT’s were included. Primary analysis was per-
formed on the 4 RCT’s who fulfilled the preset criteria for ERAS
and conventional recovery strategies, and a sensitivity analysis on
all 6 studies was performed. The 4 studies included 237 patients,
119 receiving ERAS and 118 receiving conventional treatment,
whereas the 6 RCT included 452 patients, with 226 patients in
both groups.
Primary outcome measures
As our most important outcome parameter, reflecting safety of
the intervention, complications, including mortality was analysed.
The total number of complications was relatively large in both
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groups. ERAS patients developed significantly less complications
overall (RR 0.52; 95% CI 0.38 to 0.71, p<0.0001). When di-
vided into major and minor complications, however, no signifi-
cant difference in major (RR 0.45; 95% CI 0.09 to 2.32, p=0.34)
or minor (RR 0.63; 95% CI 0.38 to 1.05, p=0.07) complications
was found. These analyses suggest that ERAS is a safe treatment
protocol and does not lead to more complications. When lesser
quality studies were added to the analysis, the effect remained the
same. However, there was heterogeneity in this analysis, especially
in combined complications. Theway complications were recorded
was not constant between studies, nor were definitions of com-
plications. Also, complications were scored in hospital treatment,
and since the overall hospital stay differed between studies (partly
because of types of surgery included) it is unclear whether all com-
plications were recorded. It is nonetheless not likely that major
complications would not be recorded, even when presenting after
discharge.
The risk of readmissions was not increased with ERAS patients,
while the primary length of hospital stay was shorter in ERAS
treated patients (MD -2.94 days; 95% CI -3.69 to -2.19). How-
ever, insufficient data concerning the effect of readmission on total
length of stay was reported, so total length of hospital stay could
not be analysed. But since the number of readmissions is not dif-
ferent between ERAS and conventional groups, the effect would
be minimal.
Length of hospital stay was significantly reduced in the ERAS
group. However, since a primary goal of the intervention is reduc-
ing hospital stay, bias may have occurred in this outcome param-
eter. Additionally, we do not feel that hospital stay is a medically
important outcome parameter. This in accordance with GRADE
methodology, as presented by Guyatt (Guyatt 2008), in which
the importance of an outcome to patients is put as the central
perspective to establish importance of outcome parameters. Other
secondary outcome parameters were divers, and no meta analyses
could be performed. However, reported outcomes like return of
gastrointestinal function and pain, seem to favour the ERAS pro-
tocol as well.
The results therefore seem to advocate the use of an ERAS pro-
tocol as standard care. More large trials with more quality control
can provide more power and may prove ERAS to be superior to
conventional care.
The use of analgesics and especially the use of epidural analge-
sia was studied in two trials, with contradictory results. Anderson
2003 used EDA for ERAS patients, and PCA morphine for con-
trols. This study showed excellent analgesia in ERAS patients, with
no significant differences in pain levels before and after surgery.
Pain was however significantly higher for controls, an effect which
continued to day 7 postoperatively, suggesting a superiority in us-
ing EDA. However, Serclova 2009, besides using standard epidu-
rals in ERAS patients, also used EDA in 68% of control patients
and still reported significant lower pain scores in the ERAS group.
However, failure rates were higher in the conventional EDA’s, and
no analysis between both subgroups with effective epidurals was
made.
Overall completeness and applicability of
evidence
Several outcome parameters possibly aiding in an advice on im-
plementation of the ERAS protocol are not available in literature.
Mostly, long term outcome parameters like oncological survival,
quality of life after surgery are not investigated yet. Also, econom-
ical effects of the intervention have not been investigated prospec-
tively, although retrospective evidence on cost effectiveness is now
available (Sammour 2010). Measures like cost effectiveness and
implementation costs have not been explored.
Furthermore, evidence on the effects of ERAS with different op-
erative techniques like laparoscopy have not been analysed. The
combination of ERAS and laparoscopy could make a difference
in primary outcome parameters. Also, all included studies focus
on the differences between “full” ERAS programs and conven-
tional recovery strategies. The effect of separate interventions in
the ERAS protocol have not been independently studied. This
analysis is nonetheless very important, because the exact value of
the separate interventions is not known, so further optimisation
of ERAS protocols is more difficult. Exact knowledge on separate
effects could also aid in making ERAS programs more (cost-) ef-
ficient and effective.
Quality of the evidence
All included studies were classified as Randomised Controlled Tri-
als. However, methodological quality was not high (Summary of
findings for the main comparison). None of the included trials
used allocation concealment or blinding. This is hard to achieve
in trials concerning complex interventions and surgical research.
However, it may introduce bias that influences results. One trial
proved this, by analysing the effect on hospital stay in comparing
results by type of surgeon; they had both traditional surgeons and
an ERAS surgeons caring for analysed patients. Analysis showed
that a traditional surgeon caring for ERAS patients had longer
lengths of stay than an ERAS surgeon, while ERAS surgeons treat-
ing conventional groups actually discharged patients earlier. This
suggests that effects on length of stay between groups, could actu-
ally be caused by the mind set of staff, rather than the patients.
All studies used length of hospital stay as the primary research
question, implying this is a medically important parameter and
reflects quality of recovery. No proof of this hypothesis exists how-
ever, and since primary research questions influence the study pro-
tocol this may produce bias in secondary outcome measures, as
defined as complications. We feel this should be the most impor-
tant primary outcome parameter, since this is the only quantative
measure of safety and the primary goal of an intervention-com-
parison. Most studies used a power analysis for their inclusion,
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calculating expected effect on the length of stay parameter, thereby
not calculating the number of patients needed to adequately reach
significance on the null hypothesis for equality in complications.
The sequence generation progress was also deemed unclear inmost
included studies, since most used an envelope method, which is
prone to abuse. Selection bias is however less likely, because of
contemporary groups and in some instances even “worse” patients
(based on age, ASA and resections) in the ERAS group.
Another major problem with the evidence was identified however.
None of the studies adequately reported on compliance with pro-
tocols or actions to prevent mixing of protocols (cross contami-
nation). Therefore, the measured effects might easily be under- or
overestimated.Moreover, itmakes it less likely to identify elements
in the ERAS protocols that are more or less important in reaching
the goals of ERAS. We feel that in these studies, since some of the
ERAS items were in fact used in conventional protocols, these ef-
fects would sooner be underestimated and that stringent monitor-
ing of protocol compliance and explicit separation between con-
ventional therapy and a full ERAS package could result in better
outcome.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The use of ERAS programs in peri-operative care for abdominal
(ileo-) colorectal surgery seems safe. Implementation in the iden-
tified RCT’s showed a reduction in overall complications in the
ERAS group, while procuring a decrease in hospital length of stay.
However, major complications were not reduced, and the effect
was due to a reduction in undefined complications in a single trial.
More large studies, with more stringent quality criteria may im-
prove power and provide proof of reducing complications. In the
field, a common idea is although releasing patients earlier, ERAS
leads to more readmissions. Although patients were released ear-
lier, surprisingly no increase in readmissions have been observed.
This while an 30 day follow up period was used, so it is unlikely
any complications as reason for readmission were missed.
Although not statistically significant, It seems, however, that ERAS
does decrease complications.However, available data does not pro-
vide proof that ERAS is superior to conventional technique and
more evidence should be provided, as well as the quality of per-
formed trials should be higher in order to adequately advocate
using ERAS as the golden standard of care.
Available data does not provide insight into the effect of protocol
adherence or implementation follow up. Simply implementing
an ERAS protocol does not ensure results as found in this meta
analysis; stringent overseeing of protocol adherence by all staff, as
well as continued alertness for decreasing compliance also seems
necessary, as many colleagues involved in ERAS implementations
have found.
The results of this review are focused on relatively healthy patients,
as most included subjects were ASA 1 or 2. No data exists, there-
fore, to guarantee safety of implementing an ERAS protocol in a
population with extended co-morbidity or higher age.
Implications for research
The number of studies found was relatively low, and aforemen-
tioned quality issues may bias results significantly. Therefore more
large trials with better separation between conventional and ERAS
protocols andmonitoring of protocol compliance seems necessary.
Furthermore, in light of current evidence, we feel ERAS should
not be considered the new standard of care (yet).
Long term data on outcome, as well as important other factors in
making a decision for an intervention, are also lacking. Quality
of life data and data on physiological performance after 30 days
have never been described, nor have data on cost-effectiveness
or economic evaluations of ERAS programs. These parameters
could play an important part in recommending ERAS treatment
in colorectal surgery.
We have identified a large ongoing RCT (Wind 2006) and one
prospective cohort study (Reurings 2009) that should provide
more data in trials that more stringently separate intervention and
control groups.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Anderson 2003
Methods Mono center RCT
- Loss to follow-up: 0
- Intention to treat: ns
- Sample size calculations: no
- Contemporary groups: yes
- Exclusion after randomisation: 2 (peri-operative change in resection)
Participants Diagnosis: 11 intervention/7 control malignant disease
inclusion: patients living independently at home needing elective hemicolectomy left/right
exclusion criteria: nr
Interventions traditional surgical care vs ERAS protocol
no predefined ERAS interventions: 12 ERAS/ 0 conventional
Location: right hemicolectomy 9/5, left hemicolectomy 5/6
Outcomes follow up: 30 days
Primary and secondary outcomes: length of hospital stay.
Measured outcomes: Hand grip strength, FEV1, time to return to normal diet, pain and fatigue
scores
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk Envelope randomisation, sequence unclear.
Allocation concealment? High risk All patients cared for by single surgeon; known
treatment protocol
Blinding?
All outcomes
High risk nor patient nor surgeon blinded, outcome asses-
sor unclear.
Free of selective reporting? Low risk all data reported
Free of other bias? High risk both patient groups cared for on same ward, pos-
sibly introducing confounding in treatment ef-
fect
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Delaney 2003
Methods Mono center RCT
- Loss to follow-up: 0
- Intention to treat: Yes
- Sample size calculations: Yes, based on own data 64 patients needed
- Contemporary groups: yes, ERAS patients were significantly older
- Exclusion after randomisation: 0
Participants Diagnosis: Intervention Crohn 9/UC8/malignant 9/diverse 3/other 2 Control 9/17/2/4/1
inclusion: All patient with elective segmental intestinal or rectal resection by laparotomy, including
re operations, pelvic surgery and comorbidity
exclusion: loop ileostomy closure and ventral hernia repair without scheduled intestinal resection
Interventions traditional surgical care vs ERAS protocol
no predefined ERAS interventions: 4 ERAS/ 0 conventional
Location: small intestine 5/5, colon 6/11, small intestine+rectum 6/15, colon+rectum7/7
Outcomes follow up: 30 days
Primary outcome: primary and total length of hospital stay.
Secondaryoutcome: effect of patients <70, effect of surgeon experience, effect of diverting ileostomy
Measured outcomes: LOS, TLOS, enteric function, reinsertion nasogastric tubes, readmissions,
complications, Pain scores, quality of life scores, hospital satisfaction
Notes patients under 70 more effect, ERAS patients cared for by ERAS surgeon more effect (ns), no effect
of ileostomy
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk sealed envelopes, created by biostatistics depart-
ment. envelope selection method unspecified
Allocation concealment? High risk
Blinding?
All outcomes
High risk nor patients nor surgeons
Free of selective reporting? Low risk all recorded data reported
Free of other bias? High risk both patient groups cared for on same ward, pos-
sibly introducing confounding in treatment ef-
fect
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Gatt 2005
Methods Mono centre RCT
- Loss to follow-up: 0
- Intention to treat:no
- Sample size calculations: yes, 19/ group
- Contemporary groups: yes
- Exclusion after randomisation: 5 (2 emergency surgery, 2 envisaged to require extensive hospital
stay unrelated to surgery, 1 no resection)
Participants Diagnosis: malignant ERAS12/ conventional 15
inclusion: All patients requiring elective colorectal surgery, living independently at home
exclusion: Age <18, pregnancy, intolerance to pro-/prebiotic’s, contraindication to one or more
optimisation strategy, contraindications to early discharge, prescribed medications that may inde-
pendently prolong hospital stay, advanced malignancy, palliative or emergency surgery, failure to
perform colonic or rectal resection
Interventions traditional surgical care vs ERAS protocol
no predefined ERAS interventions: 12 ERAS/ 1 conventional, all analgesia same as optimised group
Location: (ERAS/conv) right hemicolectomy 5/5, left hemicolectomy 2/0, sigmoid 0/2, Hartmann
1/0, anterior 5/10, subtotal colectomy 3/0, pan proctocolectomy 2/1, pan proctocolectomy with
pouch 0/1, abdoperineal resection 2/0
Outcomes follow up: 30 days
Primary outcome: hand grip strength
Secondary outcome: length of hospital stay
Measured outcomes: physiological function (spirometry, duration of catheterization, fluid balance,
time to mobilisation), Psychological function (cognitive, fatigue and pain scoring, analgesic re-
quirements), Gut function (duration of iv fluids and time to tolerance of fluids and diet), Clinical
outcome (length of hospital stay, complications and death, need for readmissions, general practi-
tioner visits)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk Randomization using sealed envelopes, sequence
unknown
Allocation concealment? High risk in an attempt to decrease bias, discharge criteria
were standardized
Blinding?
All outcomes
High risk nor patient, nor surgeon, nor outcome assessor
Free of selective reporting? Low risk all outcome measures registered also reported
Free of other bias? High risk both patient groups cared for on same ward, pos-
sibly introducing confounding in treatment ef-
fect
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Khoo 2007
Methods Mono centre RCT
- Loss to follow-up: unclear
- Intention to treat: yes, except for pre-/perioperative exclusions
- Sample size calculations: yes, 45/ group.
- Contemporary groups: yes, also pre-randomisation stratified for sex and planned TME
- Exclusion after randomisation: 11 (7 post randomisation metastatic disease, 1 not operated, 3
withdrew consent before surgery, 1 after surgery; data included in intention to treat analysis)
Participants Diagnosis: Colonic surgery (ERAS/ conventional) 22/25, rectal surgery with TME 13/10
inclusion: All elective colorectal malignancy, able to walk >100m, curative surgery
exclusion: palliative surgery, depression, contraindication for epidural analgesia
Interventions traditional surgical care vs ERAS protocol
no predefined ERAS interventions: 9 ERAS (10, because partial transverse incisions performed)/ 2
conventional (3, also partial transverse incisions)
Location: colon 22/25, rectal 13/10
Outcomes follow up: 10-14 days
Primary outcome: length of hospital stay
Secondaryoutcome: complications, mortality, readmissions
Measured outcomes: intravenous volume given first 47 hours, achievement of discharge criteria,
readmissions, complications, postdischarge outcomes, length of hospital stay,
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Central randomisation using random number
generator, randomised by telephone
Allocation concealment? High risk patients and staff aware of allocation
Blinding?
All outcomes
High risk nor patients, nor staff, patients treated in separate
hospital wards
Free of selective reporting? Unclear risk no reporting on measured outcome
Free of other bias? Low risk
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Muller 2009
Methods Multi-center RCT (4 hospitals)
- Loss to follow-up: 0
- Intention to treat: yes
- Sample size calculations: yes, 231 patients per group; After interim analysis, study stopped at 156
inclusions, 151 patients completed study
- Contemporary groups: slight difference in median age, indications not listed
- Exclusion after randomisation: 0
Participants Diagnosis: not listed
inclusion: older than 18, open elective colonic resection with primary anastomosis
exclusion: emergency surgery, contraindications to epidural analgesia, scheduled total colectomy
or rectum resection and preoperatively immobile patients
Interventions traditional surgical care vs ERAS protocol
no predefined ERAS interventions: 6 ERAS/ 4 conventional
Location: Left hemicolectomy or sigmoidectomy 50/51, transverse colectomy 0/2, right hemicolec-
tomy 26/22
Outcomes follow up: 30 days
Primary outcome: complications
Secondaryoutcome:
Measured outcomes: total and intra-operative fluid administration, oral food intake and mobilisa-
tion time
Notes oral food intake and mobilisation time were registered by patient self-assessment
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk online software, stratified for centre
Allocation concealment? High risk
Blinding?
All outcomes
High risk
Free of selective reporting? Low risk
Free of other bias? High risk certain outcome measures recorded by patient
self assessment; since ERAS patients are encour-
aged to eat and mobilise, reporting bias may be
present. Both patient groups cared for on same
ward, possibly introducing confounding in treat-
ment effect
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Serclova 2009
Methods Mono centre RCT
- Loss to follow-up: 0
- Intention to treat: yes
- Sample size calculations: Yes, depending on outcome between 30 and 47 patients per group
- Contemporary groups: Yes, although sex significantly different between intervention and control
- Exclusion after randomisation: Yes, 2 in ERAS group
Participants Diagnosis: Intervention Crohn 42, UC 4 FAP 1, Carcinoma 3, other 1. Control 38/5/4/4/1
inclusion: All patients ASA I or II, aged between 18-70, with elective open intestinal resection
exclusion: age <19, >70, ASA III/IV, Pregnancy, Pelvic radiation and multiorgan resection
Interventions traditional surgical care vs ERAS protocol
no predefined ERAS interventions: 11 ERAS/ 1 conventional (68% epidural)
Location:unspecified
Outcomes follow up: 30 days
Primary outcome: safety of protocol
Secondaryoutcome: improved pain management, shortened length of stay
Measured outcomes: length of stay, VAS pain scores, time to bowel movement, time to normal diet,
complications
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk sequence generated by statistician
Allocation concealment? High risk nor patients nor staff
Blinding?
All outcomes
High risk nor patients, nor staff or outcome assessor
Free of selective reporting? High risk BMI and severity of surgery recorded, not re-
ported
Free of other bias? High risk possible selection bias, since centre is specialized
for IBDsurgery. Both patient groups cared for on
same ward, possibly introducing confounding in
treatment effect
UC= Ulcerative colitis, nr= not reported, ns= not significant, LOS= primary length of stay, TLOS= total length of stay, FAP=Familiar
adenomatosis polyposis
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Basse 2005 All participants received enhanced recovery programs, randomisation was between open and laparoscopic procedure
Holte 2007 Both groups receiving ERAS treatment
King 2006 both groups received ERAS treatment
King 2008 both groups received ERAS treatment
Kuzma 2008 only patients with appendectomy included
Liu 2008 poor quality, pseudo randomised
MacKay 2006 both groups received ERAS treatment
Noblett 2006 all patients received ERAS pathway
Raue 2004 comparison laparoscopic ERAS vs conventional; insufficient randomisation, conventional pathway containsmultiple
ERAS interventions
Xu 2007 pseudo randomised trial
Zutshi 2004 Outcome values restricted to activity and length of stay, no follow up
Zutshi 2005 All patients received ERAS pathways, and randomised between epidural analgesia and PCA morphine
Characteristics of ongoing studies [ordered by study ID]
Reurings 2009
Trial name or title A prospective cohort study to investigate cost-minimisation, of Traditional open, open fAst track recovery
and laParoscopic fASt track multimodal management, for surgical patients with colon carcinomas. (TAPAS
study)
Methods Prospective cohort trial, multicenter. 3 cohorts, included sequentially
Participants Patients, ASA 1 or 2 aged 18 or over with colon carcinoma without metastasis
Interventions three cohorts; conventional treatment, ERAS treatment, laparoscopic surgery with ERAS treatment
Outcomes Morbidity and mortality, cost effectiveness, quality of life
Starting date 1-1-07
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Reurings 2009 (Continued)
Contact information J.C Reurings, St Elisabeth hospital Tilburg, department of surgery
Notes
Wind 2006
Trial name or title Perioperative strategy in colonic surgery; LAparoscopy and/or FAst track multimodal management versus
standard care (LAFA trial)
Methods Randomized Clinical Trial; double blinded, multicenter trial with a 2 x 2 balanced factorial design
Participants Patients eligible for segmental colectomy for malignant colorectal disease i.e. right and left colectomy and
anterior resection will be randomised to either open or laparoscopic colectomy, and to either standard care or
the fast track program
Interventions This factorial design produces four treatment groups; open colectomy with standard care (a), open colectomy
with fast track program (b), laparoscopic colectomy with standard care (c), and laparoscopic surgery with fast
track program (d)
Outcomes Primary outcome parameter is postoperative hospital length of stay including readmission within 30 days.
Secondary outcome parameters are quality of life two and four weeks after surgery, overall hospital costs,
morbidity, patient satisfaction and readmission rate
Starting date
Contact information Department of Surgery, Academic Medical Center Amsterdam, The Netherlands. j.wind@amc.uva.nl
Notes Inclusion for this study has finished, data analysis is underway
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D A T A A N D A N A L Y S E S
Comparison 1. Primary analyses ERAS versus conventional
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Mortality 4 237 Risk Ratio (M-H, Fixed, 95% CI) 0.53 [0.12, 2.38]
2 All complications 4 237 Risk Ratio (M-H, Random, 95% CI) 0.52 [0.38, 0.71]
3 Major Complications 3 134 Risk Ratio (M-H, Random, 95% CI) 0.45 [0.09, 2.32]
4 Minor complications 3 134 Risk Ratio (M-H, Random, 95% CI) 0.63 [0.37, 1.05]
5 Undefined complications 1 103 Risk Ratio (M-H, Random, 95% CI) 0.42 [0.23, 0.75]
6 Readmissions 4 237 Risk Ratio (M-H, Random, 95% CI) 0.87 [0.08, 9.39]
7 hospital stay 4 237 Mean Difference (IV, Fixed, 95% CI) -2.94 [-3.69, -2.19]
Comparison 2. Sensitivity analyses ERAS vs conventional
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 mortality 6 452 Risk Ratio (M-H, Random, 95% CI) 0.53 [0.09, 3.15]
2 Total complications 6 452 Risk Ratio (M-H, Fixed, 95% CI) 0.51 [0.39, 0.67]
3 Major complications 5 349 Risk Ratio (M-H, Fixed, 95% CI) 0.50 [0.28, 0.92]
4 Minor complications 5 349 Risk Ratio (M-H, Fixed, 95% CI) 0.57 [0.38, 0.85]
5 Undefined complications 1 103 Risk Ratio (M-H, Fixed, 95% CI) 0.42 [0.23, 0.75]
6 readmissions 6 452 Risk Ratio (M-H, Fixed, 95% CI) 0.79 [0.36, 1.76]
7 hospital stay 6 452 Mean Difference (IV, Random, 95% CI) -2.51 [-3.54, -1.47]
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Analysis 1.1. Comparison 1 Primary analyses ERAS versus conventional, Outcome 1 Mortality.
Review: Fast track surgery versus conventional recovery strategies for colorectal surgery
Comparison: 1 Primary analyses ERAS versus conventional
Outcome: 1 Mortality
Study or subgroup ERAS Conventional Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Anderson 2003 0/14 1/11 0.27 [ 0.01, 5.97 ]
Gatt 2005 1/19 0/20 3.15 [ 0.14, 72.88 ]
Khoo 2007 0/35 2/35 0.20 [ 0.01, 4.02 ]
Serclova 2009 0/51 0/52 0.0 [ 0.0, 0.0 ]
Total (95% CI) 119 118 0.53 [ 0.12, 2.38 ]
Total events: 1 (ERAS), 3 (Conventional)
Heterogeneity: Chi2 = 1.83, df = 2 (P = 0.40); I2 =0.0%
Test for overall effect: Z = 0.82 (P = 0.41)
0.1 0.2 0.5 1 2 5 10
ERAS Conventional
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Analysis 1.2. Comparison 1 Primary analyses ERAS versus conventional, Outcome 2 All complications.
Review: Fast track surgery versus conventional recovery strategies for colorectal surgery
Comparison: 1 Primary analyses ERAS versus conventional
Outcome: 2 All complications
Study or subgroup ERAS Conventional Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Anderson 2003 5/14 7/11 14.1 % 0.56 [ 0.24, 1.29 ]
Gatt 2005 9/19 15/20 33.9 % 0.63 [ 0.37, 1.08 ]
Khoo 2007 9/35 18/35 23.3 % 0.50 [ 0.26, 0.96 ]
Serclova 2009 11/51 27/52 28.6 % 0.42 [ 0.23, 0.75 ]
Total (95% CI) 119 118 100.0 % 0.52 [ 0.38, 0.71 ]
Total events: 34 (ERAS), 67 (Conventional)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.17, df = 3 (P = 0.76); I2 =0.0%
Test for overall effect: Z = 4.07 (P = 0.000046)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours eras Favours conventional
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Analysis 1.3. Comparison 1 Primary analyses ERAS versus conventional, Outcome 3 Major Complications.
Review: Fast track surgery versus conventional recovery strategies for colorectal surgery
Comparison: 1 Primary analyses ERAS versus conventional
Outcome: 3 Major Complications
Study or subgroup ERAS Conventional Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Anderson 2003 1/14 2/11 27.5 % 0.39 [ 0.04, 3.79 ]
Gatt 2005 4/19 3/20 41.5 % 1.40 [ 0.36, 5.46 ]
Khoo 2007 1/35 9/35 31.0 % 0.11 [ 0.01, 0.83 ]
Total (95% CI) 68 66 100.0 % 0.45 [ 0.09, 2.32 ]
Total events: 6 (ERAS), 14 (Conventional)
Heterogeneity: Tau2 = 1.20; Chi2 = 4.70, df = 2 (P = 0.10); I2 =57%
Test for overall effect: Z = 0.95 (P = 0.34)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours ERAS Favours conventional
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Analysis 1.4. Comparison 1 Primary analyses ERAS versus conventional, Outcome 4 Minor complications.
Review: Fast track surgery versus conventional recovery strategies for colorectal surgery
Comparison: 1 Primary analyses ERAS versus conventional
Outcome: 4 Minor complications
Study or subgroup ERAS Conventional Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Anderson 2003 4/14 5/11 23.8 % 0.63 [ 0.22, 1.80 ]
Gatt 2005 5/19 12/20 37.9 % 0.44 [ 0.19, 1.01 ]
Khoo 2007 8/35 9/35 38.3 % 0.89 [ 0.39, 2.04 ]
Total (95% CI) 68 66 100.0 % 0.63 [ 0.37, 1.05 ]
Total events: 17 (ERAS), 26 (Conventional)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.39, df = 2 (P = 0.50); I2 =0.0%
Test for overall effect: Z = 1.79 (P = 0.074)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours ERAS Favours conventional
Analysis 1.5. Comparison 1 Primary analyses ERAS versus conventional, Outcome 5 Undefined
complications.
Review: Fast track surgery versus conventional recovery strategies for colorectal surgery
Comparison: 1 Primary analyses ERAS versus conventional
Outcome: 5 Undefined complications
Study or subgroup ERAS Conventional Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Serclova 2009 11/51 27/52 100.0 % 0.42 [ 0.23, 0.75 ]
Total (95% CI) 51 52 100.0 % 0.42 [ 0.23, 0.75 ]
Total events: 11 (ERAS), 27 (Conventional)
Heterogeneity: not applicable
Test for overall effect: Z = 2.94 (P = 0.0033)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours ERAS Favours conventional
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Analysis 1.6. Comparison 1 Primary analyses ERAS versus conventional, Outcome 6 Readmissions.
Review: Fast track surgery versus conventional recovery strategies for colorectal surgery
Comparison: 1 Primary analyses ERAS versus conventional
Outcome: 6 Readmissions
Study or subgroup ERAS Conventional Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Anderson 2003 0/14 0/11 0.0 [ 0.0, 0.0 ]
Gatt 2005 1/19 4/20 0.26 [ 0.03, 2.15 ]
Khoo 2007 3/35 1/35 3.00 [ 0.33, 27.46 ]
Serclova 2009 0/51 0/52 0.0 [ 0.0, 0.0 ]
Total (95% CI) 119 118 0.87 [ 0.08, 9.39 ]
Total events: 4 (ERAS), 5 (Conventional)
Heterogeneity: Tau2 = 1.75; Chi2 = 2.44, df = 1 (P = 0.12); I2 =59%
Test for overall effect: Z = 0.12 (P = 0.91)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
ERAS Conventional
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Analysis 1.7. Comparison 1 Primary analyses ERAS versus conventional, Outcome 7 hospital stay.
Review: Fast track surgery versus conventional recovery strategies for colorectal surgery
Comparison: 1 Primary analyses ERAS versus conventional
Outcome: 7 hospital stay
Study or subgroup ERAS Conventional
Mean
Difference Weight
Mean
Difference
N Mean(SD)[days] N Mean(SD)[days] IV,Fixed,95% CI IV,Fixed,95% CI
Anderson 2003 14 4 (1.8) 11 7 (2.1) 23.4 % -3.00 [ -4.56, -1.44 ]
Gatt 2005 19 6.6 (4.4) 20 9 (4.6) 7.1 % -2.40 [ -5.22, 0.42 ]
Khoo 2007 35 5 (8.5) 35 7 (14.75) 1.8 % -2.00 [ -7.64, 3.64 ]
Serclova 2009 51 7.4 (1.3) 52 10.4 (3.1) 67.8 % -3.00 [ -3.92, -2.08 ]
Total (95% CI) 119 118 100.0 % -2.94 [ -3.69, -2.19 ]
Heterogeneity: Chi2 = 0.27, df = 3 (P = 0.97); I2 =0.0%
Test for overall effect: Z = 7.65 (P < 0.00001)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
ERAS Conventional
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Analysis 2.1. Comparison 2 Sensitivity analyses ERAS vs conventional, Outcome 1 mortality.
Review: Fast track surgery versus conventional recovery strategies for colorectal surgery
Comparison: 2 Sensitivity analyses ERAS vs conventional
Outcome: 1 mortality
Study or subgroup ERAS conventional Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Anderson 2003 0/14 1/11 0.27 [ 0.01, 5.97 ]
Delaney 2003 0/31 0/33 0.0 [ 0.0, 0.0 ]
Gatt 2005 1/19 0/20 3.15 [ 0.14, 72.88 ]
Khoo 2007 0/35 2/35 0.20 [ 0.01, 4.02 ]
Muller 2009 0/76 0/75 0.0 [ 0.0, 0.0 ]
Serclova 2009 0/51 0/52 0.0 [ 0.0, 0.0 ]
Total (95% CI) 226 226 0.53 [ 0.09, 3.15 ]
Total events: 1 (ERAS), 3 (conventional)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.83, df = 2 (P = 0.40); I2 =0.0%
Test for overall effect: Z = 0.69 (P = 0.49)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
ERAS Conventional
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Analysis 2.2. Comparison 2 Sensitivity analyses ERAS vs conventional, Outcome 2 Total complications.
Review: Fast track surgery versus conventional recovery strategies for colorectal surgery
Comparison: 2 Sensitivity analyses ERAS vs conventional
Outcome: 2 Total complications
Study or subgroup ERAS conventional Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Anderson 2003 5/14 7/11 7.5 % 0.56 [ 0.24, 1.29 ]
Delaney 2003 7/31 10/33 9.2 % 0.75 [ 0.32, 1.71 ]
Gatt 2005 9/19 15/20 13.9 % 0.63 [ 0.37, 1.08 ]
Khoo 2007 9/35 18/35 17.1 % 0.50 [ 0.26, 0.96 ]
Muller 2009 13/76 28/75 26.8 % 0.46 [ 0.26, 0.81 ]
Serclova 2009 11/51 27/52 25.4 % 0.42 [ 0.23, 0.75 ]
Total (95% CI) 226 226 100.0 % 0.51 [ 0.39, 0.67 ]
Total events: 54 (ERAS), 105 (conventional)
Heterogeneity: Chi2 = 2.05, df = 5 (P = 0.84); I2 =0.0%
Test for overall effect: Z = 4.92 (P < 0.00001)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours experimental Favours control
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Analysis 2.3. Comparison 2 Sensitivity analyses ERAS vs conventional, Outcome 3 Major complications.
Review: Fast track surgery versus conventional recovery strategies for colorectal surgery
Comparison: 2 Sensitivity analyses ERAS vs conventional
Outcome: 3 Major complications
Study or subgroup ERAS conventional Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Anderson 2003 1/14 2/11 8.0 % 0.39 [ 0.04, 3.79 ]
Delaney 2003 5/31 7/33 24.2 % 0.76 [ 0.27, 2.15 ]
Gatt 2005 4/19 3/20 10.4 % 1.40 [ 0.36, 5.46 ]
Khoo 2007 1/35 9/35 32.2 % 0.11 [ 0.01, 0.83 ]
Muller 2009 3/76 7/75 25.2 % 0.42 [ 0.11, 1.57 ]
Total (95% CI) 175 174 100.0 % 0.50 [ 0.28, 0.92 ]
Total events: 14 (ERAS), 28 (conventional)
Heterogeneity: Chi2 = 5.07, df = 4 (P = 0.28); I2 =21%
Test for overall effect: Z = 2.23 (P = 0.026)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours experimental Favours control
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Analysis 2.4. Comparison 2 Sensitivity analyses ERAS vs conventional, Outcome 4 Minor complications.
Review: Fast track surgery versus conventional recovery strategies for colorectal surgery
Comparison: 2 Sensitivity analyses ERAS vs conventional
Outcome: 4 Minor complications
Study or subgroup ERAS conventional Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Anderson 2003 4/14 5/11 11.1 % 0.63 [ 0.22, 1.80 ]
Delaney 2003 2/31 3/33 5.8 % 0.71 [ 0.13, 3.97 ]
Gatt 2005 5/19 12/20 23.2 % 0.44 [ 0.19, 1.01 ]
Khoo 2007 8/35 9/35 17.9 % 0.89 [ 0.39, 2.04 ]
Muller 2009 10/76 21/75 42.0 % 0.47 [ 0.24, 0.93 ]
Total (95% CI) 175 174 100.0 % 0.57 [ 0.38, 0.85 ]
Total events: 29 (ERAS), 50 (conventional)
Heterogeneity: Chi2 = 1.89, df = 4 (P = 0.76); I2 =0.0%
Test for overall effect: Z = 2.78 (P = 0.0055)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours experimental Favours control
Analysis 2.5. Comparison 2 Sensitivity analyses ERAS vs conventional, Outcome 5 Undefined complications.
Review: Fast track surgery versus conventional recovery strategies for colorectal surgery
Comparison: 2 Sensitivity analyses ERAS vs conventional
Outcome: 5 Undefined complications
Study or subgroup ERAS conventional Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Serclova 2009 11/51 27/52 100.0 % 0.42 [ 0.23, 0.75 ]
Total (95% CI) 51 52 100.0 % 0.42 [ 0.23, 0.75 ]
Total events: 11 (ERAS), 27 (conventional)
Heterogeneity: not applicable
Test for overall effect: Z = 2.94 (P = 0.0033)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours experimental Favours control
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Analysis 2.6. Comparison 2 Sensitivity analyses ERAS vs conventional, Outcome 6 readmissions.
Review: Fast track surgery versus conventional recovery strategies for colorectal surgery
Comparison: 2 Sensitivity analyses ERAS vs conventional
Outcome: 6 readmissions
Study or subgroup ERAS conventional Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Anderson 2003 0/14 0/11 0.0 [ 0.0, 0.0 ]
Delaney 2003 3/31 6/33 0.53 [ 0.15, 1.95 ]
Gatt 2005 1/19 4/20 0.26 [ 0.03, 2.15 ]
Khoo 2007 3/35 1/35 3.00 [ 0.33, 27.46 ]
Muller 2009 3/76 2/75 1.48 [ 0.25, 8.61 ]
Serclova 2009 0/51 0/52 0.0 [ 0.0, 0.0 ]
Total (95% CI) 226 226 0.79 [ 0.36, 1.76 ]
Total events: 10 (ERAS), 13 (conventional)
Heterogeneity: Chi2 = 3.29, df = 3 (P = 0.35); I2 =9%
Test for overall effect: Z = 0.57 (P = 0.57)
0.1 0.2 0.5 1 2 5 10
ERAS Conventional
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Analysis 2.7. Comparison 2 Sensitivity analyses ERAS vs conventional, Outcome 7 hospital stay.
Review: Fast track surgery versus conventional recovery strategies for colorectal surgery
Comparison: 2 Sensitivity analyses ERAS vs conventional
Outcome: 7 hospital stay
Study or subgroup ERAS conventional
Mean
Difference Weight
Mean
Difference
N Mean(SD)[days] N Mean(SD)[days] IV,Random,95% CI IV,Random,95% CI
Anderson 2003 14 4 (1.8) 11 7 (2.1) 19.3 % -3.00 [ -4.56, -1.44 ]
Delaney 2003 31 5.2 (2.5) 33 5.8 (3) 21.7 % -0.60 [ -1.95, 0.75 ]
Gatt 2005 19 6.6 (4.4) 20 9 (4.6) 9.6 % -2.40 [ -5.22, 0.42 ]
Khoo 2007 35 5 (8.5) 35 7 (14.75) 3.1 % -2.00 [ -7.64, 3.64 ]
Muller 2009 76 6.7 (4.84) 75 10.3 (4.97) 19.2 % -3.60 [ -5.17, -2.03 ]
Serclova 2009 51 7.4 (1.3) 52 10.4 (3.1) 27.1 % -3.00 [ -3.92, -2.08 ]
Total (95% CI) 226 226 100.0 % -2.51 [ -3.54, -1.47 ]
Heterogeneity: Tau2 = 0.80; Chi2 = 11.04, df = 5 (P = 0.05); I2 =55%
Test for overall effect: Z = 4.76 (P < 0.00001)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
ERAS Conventional
A D D I T I O N A L T A B L E S
Table 1. Search strategies
Database Search strategies Number of Hits
The Cochrane Library ((fast AND track) OR (ERAS) OR (En-
hanced AND recovery AND Surgery))
AND (colorectal OR colon OR Rectum
OR Sigmoid) AND (surgery OR surgical
OR procedure)
22
Pubmed ((fast AND track) OR (ERAS) OR (En-
hanced AND recovery AND Surgery) OR
(“fast track”)) AND (colorectal OR colon
OR Rectum OR Sigmoid) AND (surgery
OR surgical OR procedure)
125
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Table 1. Search strategies (Continued)
Embase Search strategy will be conducted through
the advanced search feature of EMBASE,
with the next options tagged on:
-Map to preferred terminology
-Also search as keyword-Include sub-
terms/derivatives (explosion search)
-1990 - 2009
-EMBASE Only
(((fast and track) or ERAS).mp. or fast-
track.ti,ab. or (enhanced and recovery and
surgery).mp.) AND (((resection or surgi-
cal or surgically or surgery or laparoscopy
or laparoscopic or laparoscopically or la-
paroscopy).ti,ab. or Surgery/) and (exp
colon/ or exp rectum/ or exp sigmoid/ or
rectal.ti,ab. or colonic.ti,ab. or colon.ti,ab.
or colorectal.ti,ab. or rectum.ti,ab. or sig-
moid.ti,ab.) OR exp Colorectal Surgery/
or exp Rectum Surgery/ or exp Colon
Surgery/)
AND
exp Randomization/ OR exp Controlled
Clinical Trial/ORRandomizedControlled
Trial/ OR random allocation.mp. OR
Double Blind Procedure/ OR Single Blind
Procedure/ OR Clinical Trial/ OR exp
Comparative Study/ OR exp evaluation/
OR exp follow up/ OR exp Prospective
Study/ OR control*.ti,ab. OR prospectiv*.
ti,ab. OR volunteer*.ti,ab
82
ISI WEb of Knowledge ( (Fast and Track) OR (ERAS) OR (en-
hanced AND recovery AND surgery) )
AND (colonic or colorectal OR colon OR
rectumOR rectalOR sigmoid ) AND(ran-
domized controlled trial OR controlled
clinical trial OR randomised controlled
trials OR random allocation OR double-
blindmethodOR single-blindmethodOR
clinical trial OR clinical trials OR clini-
cal trial OR ((singl* OR doubl*OR trebl*
OR tripl* ) AND (mask* OR blind* )) OR
placebos OR placebo* OR random* OR
comparative study OR evaluation stud*
OR follow-up stud* OR prospective stud*
OR control* OR prospectiv* OR volun-
teer*)
135
Webcasts of the annual meeting of ACRS Full manual search 2
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Table 1. Search strategies (Continued)
NHS Economic Evaluation Database in
the Cochrane library
((fast AND track) OR (ERAS) OR (En-
hanced AND recovery AND Surgery))
AND (colorectal OR colon OR Rectum
OR Sigmoid) AND (surgery OR surgical
OR procedure)
3
Table 2. Patient characteristics
Trial N Age Gender
(M/F)
BMI POS-
SUM
ASA 1-
2/3
ERAS/
conv
ERAS conv ERAS conv ERAS conv ERAS conv ERAS conv
Ander-
son
2003
14/11 64[55-
68]
68[65-
75]
6/8 5/6 26 [24-
28]ˆ
24 [22-
28]ˆ
26[22-
27]ˆ
26 [24-
28]ˆ
13/1† 10/1†
Delaney
2003
31/33 30.6
[16.9]ˆ
41.9
[13.3]ˆ
21/10 21/12 * * * * 3/16/12 0/26/7
Gatt
2005
19/20 67 [59-
76]
67 [60-
70]
9/10 14/6 24 [21-
29]
27[24-
30]
13[11-
15]
12[11-
16]
2[2-2]‡ 2[2-3]‡
Khoo
2007
35/35 69.
3 [46.3-
87.7]
73.
0 [46.4-
84.6]
12/23 15/20 * * * * 5/25/5 3/27/5
Muller
2009
76/75 62 [27-
91]
59 [39-
89]
37/39 40/35 24 [19-
35]
26 [17-
33]
* * 2/50/24 3/54/18
Serclova
2009
51/52 35.1[11.
0]ˆ
37.6[12.
5]ˆ
20/31 32/20 * * * * * *
conv= conventional treatment protocol
ˆ= mean [SD]
*= unreported
†= ASA 1 en 2 taken together.
‡= presented as median [interquartile range]
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